Identification of Alternative In Vitro Bioequivalence Pathways Which Can Reliably Ensure In Vivo Bioequivalence of Product Performance and Quality of Non-Systemically Absorbed Drug Products for Animals

1 organizations filed 1 public comment on Identification of Alternative In Vitro Bioequivalence Pathways Which Can Reliably Ensure In Vivo Bioequivalence of Product Performance and Quality of Non-Systemically Absorbed Drug Products for Animals, at the Food and Drug Administration. The comment window closed 3921d ago.

Abstract

Comment Request; Reopening of the Comment Period

Commenters (1)

• Animal Health Institutetrade assoc.

  1 filing · confidence 97%